CMS Announces Re-weighting of 2020 MIPS Cost Performance Category

Recently, CMS announced that due to the impact of the COVID-19 PHE, it would re-weight the cost performance category from 15% to 0% for the 2020 MIPS performance year. The 15% cost performance category weight will be redistributed to other performance categories per previously established policies. CMS has found that the volume of data available to calculate scores for cost measures has significantly decreased overall. Therefore, the agency cannot reliably calculate scores that would adequately capture and reflect the performance of MIPS-eligible clinicians. Clinicians do not need to take any action because the cost performance category relies on administrative claims data.